Myfxtools
  • Login
  • Expert Advisors
  • Forex Signals
    • Best Forex Signals
  • Forex Brokers
  • Forex Trading
    • Forex Guides
    • Analytical Tools
    • Charting Software
  • Crypto Trading
  • Portfolios
No Result
View All Result
  • Expert Advisors
  • Forex Signals
    • Best Forex Signals
  • Forex Brokers
  • Forex Trading
    • Forex Guides
    • Analytical Tools
    • Charting Software
  • Crypto Trading
  • Portfolios
  • Login
Myfxtools
  • Log In
Home News

Corcept Therapeutics Inc. Faces Setback in Patent Infringement Lawsuit

by Myfxtools
January 2, 2024
in News
Share on TwitterShare on Facebook

Corcept Therapeutics Inc. (CORT, -1.22%), a prominent pharmaceutical company, experienced a significant blow as its shares dropped by 32% in premarket trading on Tuesday. This decline comes in the wake of a ruling from a federal court in New Jersey on Friday, which sided with Teva Pharmaceutical Industries Ltd. (TEVA, -0.29%) in Corcept’s patent infringement lawsuit.

Teva’s intention to release a generic version of Corcept’s Korlym, an effective treatment for Cushing’s syndrome, prompted the legal battle. However, the court determined that Corcept failed to provide sufficient evidence of direct infringement on its patent claims regarding the drug.

Despite this setback, Corcept’s CEO, Dr. Joseph Belanoff, expressed optimism, stating that the company intends to appeal the decision vigorously. Belanoff emphasized their confidence in eventually overturning the ruling, while also asserting their commitment to protecting their intellectual property rights.

As of now, Teva has not issued any comment regarding the court’s decision.

It is worth noting that Corcept Therapeutics Inc. experienced impressive growth in 2023, with its shares witnessing a remarkable surge of around 60%. Conversely, Teva’s American depositary receipts saw a slight dip of 0.1% in premarket trading on Tuesday but demonstrated an overall gain of 14.5% over the past twelve months.

forex ea chart
Would you like to try out trading with an Expert Advisor?
Check Out Best Forex EAs Here
Tags: Corcept TherapeuticsKorlympatent infringementTeva Pharmaceutical
Previous Post

Stock Market Update: Marathon Digital Holdings, MicroStrategy See Pre-Market Gains

Next Post

Cryptocurrency Market Update

Next Post

Cryptocurrency Market Update

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

51 − 42 =

Recent Posts

  • Investors Brace for Fallout if Powell Exits Early
  • Rupee Falls for Third Week Ahead of Key Global Events
  • Dollar Sags Weekly Despite Friday Rebound, Fed Eyed
  • UK Firms Lose Momentum as BoE Balances Inflation and Jobs
  • Turkish Central Bank Resumes Rate Cuts With Aggressive Move
  • About Us
  • Contact Us
  • Privacy Policy
  • Risk Disclosure
Myfxtools turns raw trade logs into verified dashboards and AI-driven insights - helping traders see, share, and sharpen their edge.

© 2025, Myfxtools. All rights reserved.

AI Strategy Insight is educational and not financial advice.

  • Expert Advisors
  • Forex Signals
    • Best Forex Signals
  • Forex Brokers
  • Forex Trading
    • Forex Guides
    • Analytical Tools
    • Charting Software
  • Crypto Trading
  • Portfolios

© 2025, Myfxtools. All rights reserved.

AI Strategy Insight is educational and not financial advice.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In